Showing results (1511-1520 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|March 17, 2019
Inhibition of Serotonin Synthesis May Have Antitumor Activity? Long-Term Efficacy in a Patient with Gastrointestinal Neuroendocrine TumorJavier Molina-Cerrillo, Enrique Grande, Teresa Alonso-Gordoa
The Oncologist|March 17, 2019
A Single-Arm, Phase II Study of Apatinib in Refractory Metastatic Colorectal CancerXiaofeng Chen, Tianzhu Qiu, Yingwei Zhu, et al.
The Oncologist|August 18, 2019
A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2-Positive Metastatic Breast Cancer (CCTG IND.229)Stephen Chia, Phillipe L Bedard, John Hilton, et al.
The Oncologist|October 3, 2019
Real-World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10Yvette Drew, Rebecca S Kristeleit, Ana Oaknin, et al.
The Oncologist|July 19, 2019
Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?Carly C Barron, Nidhi Kumar Tyagi, Muhammad Mustafa Alhussein, et al.
The Oncologist|July 19, 2019
Individualized Prediction of Survival Benefit from Postmastectomy Radiotherapy for Patients with Breast Cancer with One to Three Positive Axillary Lymph NodesNing Zhang, Jiashu Zhang, Hanwen Zhang, et al.
The Oncologist|March 2, 2019
Hematologic Complications of Immune Checkpoint InhibitorsElizabeth J Davis, Joe-Elie Salem, Arissa Young, et al.
The Oncologist|March 2, 2019
Ongoing Phase I Studies of Immune Checkpoint Inhibitors in ChinaWenfeng Fang, Shen Zhao, Yaxiong Zhang, et al.
The Oncologist|February 20, 2019
Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?Enrico Franceschi, Alicia Tosoni, Dario De Biase, et al.
The Oncologist|March 10, 2019
Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT SeriesMartin Benesch, Martin Mynarek, Hendrik Witt, et al.
Pageof 571